NCT00262548View on ClinicalTrials.gov

C-Reactive Protein (CRP) in Obese Diabetic Women

PHASE4CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

October 31, 2005

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Rosuvastatin; improvement of lipid profile

Trial Locations (1)

Unknown

Research site, Cuernavaca

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Mexican National Institute of Public Health

OTHER_GOV

lead

AstraZeneca

INDUSTRY

NCT00262548 - C-Reactive Protein (CRP) in Obese Diabetic Women | Biotech Hunter | Biotech Hunter